T. Rowe Price Associates’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $78K | Hold |
|
|||||
|
2025
Q1 | $77K | Buy |
|
|||||
|
2024
Q4 | $111K | Sell |
|
|||||
|
2024
Q3 | $297K | Buy |
|
|||||
|
2024
Q2 | $270K | Buy |
|
|||||
|
2024
Q1 | $345K | Buy |
|
|||||
|
2023
Q4 | $133K | Buy |
|
|||||
|
2023
Q3 | $100K | Hold |
|
|||||
|
2023
Q2 | $125K | Sell |
|
|||||
|
2023
Q1 | $124K | Buy |
|
|||||
|
2022
Q4 | $86K | Buy |
|
|||||
|
2022
Q3 | $241K | Buy |
|
|||||
|
2022
Q2 | $218K | Buy |
|
|||||
|
2022
Q1 | $168K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $21.8M | Buy |
|
|||||
|
2019
Q2 | $17.1M | Buy |
|
|||||
|
2019
Q1 | $16.8M | Buy |
|
|||||
|
2018
Q4 | $7.92M | Buy |
|
|||||
|
2018
Q3 | $10.3M | Buy |
|